Kerschensteiner, Martin

Prof. Dr. Kerschensteiner is Professor of Neuroscience and Clinical Neuroimmunology and Director of the Institute of Clinical Neuroimmunology at LMU Munich. He has been a board member of the Multiple Sclerosis Competence Network since September 2016.

Since 2017: Managing Director (Deputy) of the Biomedical Center (BMC) of the LMU Munich

Since 2013: W3 Professor of Neurosciences and Clinical Neuroimmunology and Director of the Institute of Clinical Neuroimmunology at LMU Munich

Since 2012: Member of the Center for Advanced Studies at LMU Munich (CASLMU Young Academy)

Since 2010: Member of the Cluster of Excellence Task Force of the Medical Faculty of the LMU Munich

2008-2013: W2 Professor for Translational Neuroimmunology at the Institute for Clinical Neuroimmunology at LMU Munich

2005-2007: Member of the Research Committee of the LMU Munich

2005-2008: Head of an Emmy Noether Junior Research Group at the Institute for Clinical Neuroimmunology at the Ludwig-Maximilians-University Munich (LMU Munich)

2004-2005: Research Associate, Department of Molecular and Cellular Biology, Harvard University

2003-2004: Postdoctoral Fellow, Department of Anatomy and Neurobiology, Washington University School of Medicine

2001-2003: Postdoctoral researcher, Department of Neuromorphology, Institute of Brain Research, University of Zurich and ETH Zurich

2000: Doctorate at the LMU Munich

1994-1999: Doctoral thesis in the Department of Neuroimmunology, Max Planck Institute of Neurobiology, Munich

1992-1999: Studied medicine at the RWTH Aachen and the LMU Munich

  • Neuroimmunology
  • In vivo analysis of neuroinflammation
  • Mechanisms of inflammatory neurodegeneration
  • Neuroprotection and neuronal repair strategies
  • Board member of the Cluster of Excellence “Munich Cluster for Systems Neurology (SyNergy)”
  • Co-speaker of the DFG Collaborative Research Center Transregio 274 (“Checkpoints of central nervous system recovery”)
  • Board member of the DFG Collaborative Research Center Transregios 128 (“Initiating and effector vs. regulatory mechanisms in multiple sclerosis”)

Felgenhauer Prize, DGN (2014)
Member of the German National Academy of Sciences, Leopoldina (2020)
Funded by the European Research Council (ERC Consolidator Grant) (2012)
Habilitation Award of the Munich University Society for the best habilitation 2005- 2007 (2008)
Funding as part of Phase II of the DFG’s Emmy Noether Program (2005)
1. Wyeth Junior Researcher Award Multiple Sclerosis (2004)
Scholarship holder as part of Phase I of the DFG’s Emmy Noether Program (2001-2003)
1st Sobek Junior Researcher Award for Multiple Sclerosis Research (2001)

1971